Note: this report was generated Over 4 year(s) ago!
Register or Log in to update analysis!
SEO audit: aperus.navinetsolutions.com
Mobile devices
Mobile view
This website is optimal for mobile devices!
Tablet view
This website is optimal for tablet devices!
Mobile appearance
Mobile optimisation
Apple icon
Meta Tag (viewport tag, mobile devices)
Flash content
Google search result list preview
Google preview
Aperus Pharma
aperus.navinetsolutions.com/
Error! Missing "meta description" part: the page has no summary description!
Error! Missing "meta description" part: the page has no summary description!
Domain / URL audit
URL
Domain : aperus.navinetsolutions.com/
Length (characters) : 28
Length (characters) : 28
Alexa
Alexa does not have enough data about this website.
IP checking
The 104.27.180.3 ip address is not on the spam list.
SEO audit: Content analysis
Language
We have found the language localisation: ”en”.
Title
Aperus Pharma
Length (characters) : 13
Excellent! The title’s length is between 10 and 70 characters.
Excellent! The title’s length is between 10 and 70 characters.
Text / HTML ratio
Ratio : 6%
Error! The text / HTML code ratio is under 15 percent on this website. This value shows that the website has relatively few text content.
Error! The text / HTML code ratio is under 15 percent on this website. This value shows that the website has relatively few text content.
Flash
Excellent! The website does not have any flash contents.
Frame
Excellent! The website does not use iFrame solutions.
Keywords cloud
memory
learn
disease
drug
cells
company
action
intellectual
signalling
property
top
overview
pharma
family
abeta
patent
clinical
home
neuronal
protected
pipeline
process
team
data-separator=yes
mechanisms
scientific
business
partners
neurodegenerative
unique
approach
restores
email
structure
page
r&d
aperus
project
committee
against
strategy
solution
granted
history
molecule
investors
alzheimer’s
all
news
multiple
effects
marketing
candidate
diseases
amyloid
read
Keywords consistency
| Keyword | Content | Title | Description (meta description) | Headings (headings) |
|---|---|---|---|---|
| disease | 9 | |||
| alzheimer’s | 7 | |||
| candidate | 7 | |||
| aperus | 6 | |||
| drug | 5 | |||
| pharma | 5 |
| Keywords (2 words) | Content | Title | Description (meta description) | Headings (headings) |
|---|---|---|---|---|
| alzheimer’s disease | 5 | |||
| project overview | 2 | |||
| learn more | 2 | |||
| pipeline scientific | 2 | |||
| candidate intellectual | 2 | |||
| strategy news | 2 |
| Keywords (3 words) | Content | Title | Description (meta description) | Headings (headings) |
|---|---|---|---|---|
| clinical drug candidate | 2 |
Headings (headings)
| H1 | H2 | H3 | H4 | H5 | H6 |
| 2 | 2 | 3 | 3 | 2 | 6 |
Error! The number of H1 tag is more than 1.
Heading structure in the source code
- <H6> About us
- <H2> Who We Are
- <H4> Company
- <H4> Project
- <H4> Drug candidate Q134R
- <H6> Q134R – Mechanisms of Action
- <H1>
- <H1> Q134R – Mechanisms of Action
- <H6> Q134R is a strong cytoprotective agent: at nanomolecular range, it protects neuronal cells against ROS- (reactive oxygen species) and Abeta- (amyloid beta) induced neuronal death, and restores mitochondrial functioning.
- <H6> Q134R restores memory impairment caused by scopolamine or Abeta oligomers, by modulation of the GABAA gated Cl- channels, specific for extrasynaptic signalling in neurogliaform cells, belonging to a specialized type of interneurons, which modulates memory formation.
- <H6> Q134R has inhibitory effects on NFATs: a family of calcineurin- (CN) dependent transcription factors linked to the multiple pathologic hallmarks that emerge during AD. Numerous studies show that inhibition of CN/NFAT signalling leads to beneficial effects on amyloid pathology, neuroinflammation, neuronal viability, synaptic physiology, and cognitive function in mouse models of AD.
- <H6> from the blog
- <H2> Our latest News
- <H3> Avidin Publishes in Molecules the Enantioselective Synthesis of 8-Hydroxyquinoline Derivative, Q134 Which is a Hypoxic Adaptation Inducer
- <H3> Unique Drug Candidate Being Developed Against Alzheimer’s Disease Reported by PharmaOnline
- <H3> New Patent Granted in USA
- <H5> Contact Us
- <H5> Follow Us
- Expand
Images
We found 9 images on this web page.
Alternate attributes for the following 6 images are missing. Search engines use "alt" tags to understand image content efficiently. We strongly recommend fixing this issue.
Alternate attributes for the following 6 images are missing. Search engines use "alt" tags to understand image content efficiently. We strongly recommend fixing this issue.
SEO audit: Links
Search engine friendly URLs
Excellent! The website uses SEO friendly URLs.
Underscores in the URLs
Excellent! No underscore (_) found in the URLs.
Links
We found a total of 46 different links.
Internal links: 46
Internal links: 46
SEO audit: technology
Redirection (www / not www)
Error! The web address is accessible with and without www!
Favicon
Excellent! The website uses favicon.
Doctype
HTML 5
Encoding
Perfect! The character encoding is set: UTF-8.
Deprecated HTML
Excellent! No deprecated HTML tags are detected.
Printability
Suggestion! Unfortunately, no printer-friendly CSS found.
404 Page
The website has a 404 error page.
Checking the robots.txt file
There is robots.txt file.
https://aperus.navinetsolutions.com/robots.txt
https://aperus.navinetsolutions.com/robots.txt
| User-agent | Disallow (parts which have been disallowed for the search engines) |
|---|---|
| * |
|
Sitemap
Error! No sitemap found!
Google Analytics
The Google Analytics tracking code is missing.
Google Tag Manager
Suggestion! The website does not use the Google Tag Manager.
Email encryption
Excellent! We have not found any unencrypted email addresses.